News
-
-
-
COMMUNIQUÉ DE PRESSE
Redx Reports Encouraging Zamaporvint (RXC004) Phase 2 Combination Data in MSS mCRC at ESMO GI Congress Supporting Genetic Selection Hypothesis in Hard-to-Treat GI Cancers
Redx Pharma presents positive Phase 2 data on Zamaporvint (RXC004) at ESMO GI Congress, supporting genetic selection hypothesis in hard-to-treat GI cancers. Potential new treatment option for MSS mCRC patients -
-
-
COMMUNIQUÉ DE PRESSE
Industrial Technical Holdings Ltd. Announces Completion of Consolidated Audits for 2022 and 2023
Industrial Technical Holdings Ltd. completes consolidated audits for fiscal years 2022 and 2023, showcasing revenue performance, profit growth, financial position, cash flow management, equity improvement, and debt management -
-
-
-
